CN1756838A - 心血管疾病中减少的分泌性多肽种类(来自壳三糖苷酶的片段) - Google Patents

心血管疾病中减少的分泌性多肽种类(来自壳三糖苷酶的片段) Download PDF

Info

Publication number
CN1756838A
CN1756838A CNA2004800061141A CN200480006114A CN1756838A CN 1756838 A CN1756838 A CN 1756838A CN A2004800061141 A CNA2004800061141 A CN A2004800061141A CN 200480006114 A CN200480006114 A CN 200480006114A CN 1756838 A CN1756838 A CN 1756838A
Authority
CN
China
Prior art keywords
cpp
polypeptide
protein
sequence
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2004800061141A
Other languages
English (en)
Chinese (zh)
Inventor
L·布盖勒瑞特
I·屈赞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Geneprot Inc
Original Assignee
Geneprot Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geneprot Inc filed Critical Geneprot Inc
Publication of CN1756838A publication Critical patent/CN1756838A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01014Chitinase (3.2.1.14)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • C12N9/2434Glucanases acting on beta-1,4-glucosidic bonds
    • C12N9/2442Chitinase (3.2.1.14)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
CNA2004800061141A 2003-01-07 2004-01-05 心血管疾病中减少的分泌性多肽种类(来自壳三糖苷酶的片段) Pending CN1756838A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43864303P 2003-01-07 2003-01-07
US60/438,643 2003-01-07

Publications (1)

Publication Number Publication Date
CN1756838A true CN1756838A (zh) 2006-04-05

Family

ID=32713361

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2004800061141A Pending CN1756838A (zh) 2003-01-07 2004-01-05 心血管疾病中减少的分泌性多肽种类(来自壳三糖苷酶的片段)

Country Status (6)

Country Link
EP (1) EP1583828A1 (https=)
JP (1) JP2006519771A (https=)
CN (1) CN1756838A (https=)
BR (1) BRPI0406656A (https=)
CA (1) CA2512629A1 (https=)
WO (1) WO2004061096A1 (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6200951B1 (en) * 1998-03-12 2001-03-13 Icos Corporation Chitinase chitin-binding fragments
AU5299200A (en) * 1999-05-27 2000-12-18 Pharmacia & Upjohn Company A nematode drug screen for modulators of mammalian disorders

Also Published As

Publication number Publication date
EP1583828A1 (en) 2005-10-12
CA2512629A1 (en) 2004-07-22
WO2004061096A1 (en) 2004-07-22
JP2006519771A (ja) 2006-08-31
BRPI0406656A (pt) 2005-12-06

Similar Documents

Publication Publication Date Title
JP2007523844A (ja) 心臓血管障害において減少する分泌ポリペプチド種
JP2008500952A (ja) 心臓血管障害で減少する分泌ポリペプチド種
JP2007501605A (ja) 心血管疾患に関連する分泌ポリペプチド種
US20070009955A1 (en) Secreted polypeptide species associated with cardiovascular disorders
JP2005533086A5 (https=)
WO2006005583A2 (en) Secreted polypeptide species involved in multiple sclerosis
JP2006526578A (ja) 心臓血管障害で減少する分泌ポリペプチド種
JP2007513063A (ja) 心臓血管障害に関連する分泌ポリペプチド種
CN1756838A (zh) 心血管疾病中减少的分泌性多肽种类(来自壳三糖苷酶的片段)
WO2006029838A2 (en) Secreted polypeptide species involved in alzheimer’s disease
US20060148690A1 (en) Secreted peptides
WO2005019825A2 (en) Secreted polypeptide species and use thereof
WO2006005586A2 (en) New polypeptide species specific to cerebrospinal fluid
JP2006523191A (ja) 心臓血管障害に関連する分泌ポリペプチド種
JP2007527704A (ja) 心臓血管障害に関連する分泌ポリペプチド種
JP2007534611A (ja) 心臓血管障害に関連する分泌ポリペプチド種
JP2007527377A (ja) 心臓血管障害で減少される分泌ポリペプチド種
US20060147447A1 (en) Secreted peptides
WO2006005585A2 (en) Secreted polypeptide species differentially expressed during pregnancy
EP1641821A2 (en) Human secreted proteins
WO2004005331A2 (en) Peptides derived from pep133 (g1p3, 6-16)
WO2004101615A2 (en) Secreted polypeptide species associated with cardiovascular disorders

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication